JAMA Network Home
Sign In
Research Letter

GLP-1 RA Use and Survival Among Older Adults With Cancer and Type 2 Diabetes

JAMA Network Open 10.1001/jamanetworkopen.2025.21887

July 18, 2025 at 11:00 AM EDT

Read the full article

This cohort study evaluates whether older adults with type 2 diabetes and cancer have improved survival when taking glucagon-like peptide-1 receptor agonists (GLP-1RAs) compared with sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors.

Corresponding Author: Jingchuan Guo, MD, PhD, Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, 1889 Museum Rd, DSIT 6004, Gainesville, FL 32606 (guoj1@ufl.edu).

Link to the article in your story

We encourage you to link out to this article in your your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.21887?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=071825

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks